Advertisement
Screener

PTC Therapeutics, Inc. (PTCT) Increase (Decrease) in Prepaid Expense and Other Assets

2.8 / 5 stars · 68/120 Roast Me

PTC Therapeutics, Inc. Increase (Decrease) in Prepaid Expense and Other Assets

PTC Therapeutics, Inc. (PTCT) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$9.54 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-07-30

  • PTC Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$8.36M.
  • PTC Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$1.18M, a 107.18% decline year-over-year.
  • PTC Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $22.94M, a 149.53% increase year-over-year.
  • PTC Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $1.68M.
  • PTC Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $36.82M.
  • PTC Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$98.76M, a 319.51% decline from fiscal 2023.
  • PTC Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $44.99M, a 12.84% decline from fiscal 2022.
  • PTC Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $51.62M, a 237.17% increase from fiscal 2021.
Period endIncrease (Decrease) in Prepaid Expense and Other Assets 3 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 9 monthIncrease (Decrease) in Prepaid Expense and Other Assets 9 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 12 monthIncrease (Decrease) in Prepaid Expense and Other Assets 12 month as first filed
2026-06-30-$8.36M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30
-$9.54M
10-Q · filed 2026-07-30
$13.40M
derived: sum of 3 quarters · filed 2026-07-30
$15.08M
derived: sum of 4 quarters · filed 2026-07-30
2026-03-31-$1.18M
10-Q · filed 2026-05-07
$21.76M
derived: sum of 2 quarters · filed 2026-05-07
$23.44M
derived: sum of 3 quarters · filed 2026-05-07
$19.21M
derived: sum of 4 quarters · filed 2026-07-30
2025-12-31$22.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
$24.62M
derived: sum of 2 quarters · filed 2026-02-19
$20.39M
derived: sum of 3 quarters · filed 2026-07-30
$36.82M
10-K · filed 2026-02-19
2025-09-30$1.68M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
-$2.55M
derived: sum of 2 quarters · filed 2026-07-30
$13.88M
10-Q · filed 2025-11-04
$23.07M
derived: sum of 4 quarters · filed 2026-07-30
2025-06-30-$4.23M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30
$12.20M
10-Q · filed 2026-07-30
$21.39M
derived: sum of 3 quarters · filed 2026-07-30
$13.22M
derived: sum of 4 quarters · filed 2026-07-30
2025-03-31$16.43M
10-Q · filed 2026-05-07
$25.62M
derived: sum of 2 quarters · filed 2026-05-07
$17.46M
derived: sum of 3 quarters · filed 2026-05-07
$11.57M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$9.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
$1.03M
derived: sum of 2 quarters · filed 2026-02-19
-$4.86M
derived: sum of 3 quarters · filed 2026-02-19
-$98.76M
10-K · filed 2026-02-19
2024-09-30-$8.17M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
-$14.05M
derived: sum of 2 quarters · filed 2025-11-04
-$107.96M
10-Q · filed 2025-11-04
-$3.50M
derived: sum of 4 quarters · filed 2026-02-19
2024-06-30-$5.89M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
-$99.79M
10-Q · filed 2025-08-07
$4.67M
derived: sum of 3 quarters · filed 2026-02-19
$9.15M
derived: sum of 4 quarters · filed 2026-02-19
2024-03-31-$93.90M
10-Q · filed 2025-05-06
$10.55M
derived: sum of 2 quarters · filed 2026-02-19
$15.04M
derived: sum of 3 quarters · filed 2026-02-19
$8.70M
derived: sum of 4 quarters · filed 2026-02-19
2023-12-31$104.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
$108.94M
derived: sum of 2 quarters · filed 2026-02-19
$102.60M
derived: sum of 3 quarters · filed 2026-02-19
$44.99M
10-K · filed 2026-02-19
2023-09-30$4.48M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
-$1.86M
derived: sum of 2 quarters · filed 2024-11-07
-$59.47M
10-Q · filed 2024-11-07
-$43.46M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30-$6.34M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$63.95M
10-Q · filed 2024-08-08
-$47.95M
derived: sum of 3 quarters · filed 2025-02-27
$4.10M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31-$57.61M
10-Q · filed 2024-04-25
-$41.60M
derived: sum of 2 quarters · filed 2025-02-27
$10.44M
derived: sum of 3 quarters · filed 2025-02-27
$19.13M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31$16.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$68.05M
derived: sum of 2 quarters · filed 2025-02-27
$76.74M
derived: sum of 3 quarters · filed 2025-02-27
$51.62M
10-K · filed 2025-02-27
2022-09-30$52.05M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26
$60.73M
derived: sum of 2 quarters · filed 2023-10-26
$35.62M
10-Q · filed 2023-10-26
$59.09M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30$8.69M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03
-$16.43M
10-Q · filed 2023-08-03
$7.04M
derived: sum of 3 quarters · filed 2024-02-29
$14.53M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31-$25.12M
10-Q · filed 2023-04-27
-$1.65M
derived: sum of 2 quarters · filed 2024-02-29
$5.84M
derived: sum of 3 quarters · filed 2024-02-29
$5.80M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31$23.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$30.96M
derived: sum of 2 quarters · filed 2024-02-29
$30.91M
derived: sum of 3 quarters · filed 2024-02-29
$15.31M
10-K · filed 2024-02-29
2021-09-30$7.49M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27
$7.44M
derived: sum of 2 quarters · filed 2022-10-27
-$8.16M
10-Q · filed 2022-10-27
-$4.83M
derived: sum of 4 quarters · filed 2023-02-21
2021-06-30-$44.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
-$15.65M
10-Q · filed 2022-08-04
-$12.32M
derived: sum of 3 quarters · filed 2023-02-21
-$19.60M
derived: sum of 4 quarters · filed 2023-02-21
2021-03-31-$15.61M
10-Q · filed 2022-05-03
-$12.27M
derived: sum of 2 quarters · filed 2023-02-21
-$19.55M
derived: sum of 3 quarters · filed 2023-02-21
-$9.66M
derived: sum of 4 quarters · filed 2023-02-21
2020-12-31$3.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21
-$3.95M
derived: sum of 2 quarters · filed 2023-02-21
$5.95M
derived: sum of 3 quarters · filed 2023-02-21
$12.62M
10-K · filed 2023-02-21
2020-09-30-$7.28M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28
$2.61M
derived: sum of 2 quarters · filed 2021-10-28
$9.29M
10-Q · filed 2021-10-28
$6.35M
derived: sum of 4 quarters · filed 2022-02-22
2020-06-30$9.89M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29
$16.57M
10-Q · filed 2021-07-29
$13.63M
derived: sum of 3 quarters · filed 2022-02-22
$18.15M
derived: sum of 4 quarters · filed 2022-02-22
2020-03-31$6.67M
10-Q · filed 2021-05-04
$3.74M
derived: sum of 2 quarters · filed 2022-02-22
$8.26M
derived: sum of 3 quarters · filed 2022-02-22
$15.32M
derived: sum of 4 quarters · filed 2022-02-22
2019-12-31-$2.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22
$1.58M
derived: sum of 2 quarters · filed 2022-02-22
$8.64M
derived: sum of 3 quarters · filed 2022-02-22
$8.84M
10-K · filed 2022-02-22
2019-09-30$4.52M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29
$11.58M
derived: sum of 2 quarters · filed 2020-10-29
$11.77M
10-Q · filed 2020-10-29
$12.08M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30$7.06M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
$7.25M
10-Q · filed 2020-08-05
$7.56M
derived: sum of 3 quarters · filed 2021-02-25
$9.11M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$191.00K
10-Q · filed 2020-04-30
$499.00K
derived: sum of 2 quarters · filed 2021-02-25
$2.05M
derived: sum of 3 quarters · filed 2021-02-25
$2.76M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$308.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$1.86M
derived: sum of 2 quarters · filed 2021-02-25
$2.57M
derived: sum of 3 quarters · filed 2021-02-25
$1.61M
10-K · filed 2021-02-25
2018-09-30$1.55M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30
$2.26M
derived: sum of 2 quarters · filed 2019-10-30
$1.30M
10-Q · filed 2019-10-30
$2.52M
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30$704.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06
-$254.00K
10-Q · filed 2019-08-06
$960.00K
derived: sum of 3 quarters · filed 2020-03-02
$1.11M
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31-$958.00K
10-Q · filed 2019-05-02
$256.00K
derived: sum of 2 quarters · filed 2020-03-02
$410.00K
derived: sum of 3 quarters · filed 2020-03-02
$919.00K
derived: sum of 4 quarters · filed 2020-03-02
2017-12-31$1.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
$1.37M
derived: sum of 2 quarters · filed 2020-03-02
$1.88M
derived: sum of 3 quarters · filed 2020-03-02
$1.78M
10-K · filed 2020-03-02
2017-09-30$154.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05
$663.00K
derived: sum of 2 quarters · filed 2018-11-05
$570.00K
10-Q · filed 2018-11-05
$494.00K
derived: sum of 4 quarters · filed 2019-03-01
2017-06-30$509.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
$416.00K
10-Q · filed 2018-08-07
$340.00K
derived: sum of 3 quarters · filed 2019-03-01
$408.00K
derived: sum of 4 quarters · filed 2019-03-01
2017-03-31-$93.00K
10-Q · filed 2018-05-09
-$169.00K
derived: sum of 2 quarters · filed 2019-03-01
-$101.00K
derived: sum of 3 quarters · filed 2019-03-01
-$562.00K
derived: sum of 4 quarters · filed 2019-03-01
2016-12-31-$76.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01
-$8.00K
derived: sum of 2 quarters · filed 2019-03-01
-$469.00K
derived: sum of 3 quarters · filed 2019-03-01
-$1.17M
10-K · filed 2019-03-01
2016-09-30$68.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02
-$393.00K
derived: sum of 2 quarters · filed 2017-11-02
-$1.09M
10-Q · filed 2017-11-02
$264.00K
derived: sum of 4 quarters · filed 2018-03-06
2016-06-30-$461.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
-$1.16M
10-Q · filed 2017-08-09
$196.00K
derived: sum of 3 quarters · filed 2018-03-06
$588.00K
derived: sum of 4 quarters · filed 2018-03-06
2016-03-31-$702.00K
10-Q · filed 2017-05-08
$657.00K
derived: sum of 2 quarters · filed 2018-03-06
$1.05M
derived: sum of 3 quarters · filed 2018-03-06
-$826.00K
derived: sum of 4 quarters · filed 2018-03-06
2015-12-31$1.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06
$1.75M
derived: sum of 2 quarters · filed 2018-03-06
-$124.00K
derived: sum of 3 quarters · filed 2018-03-06
$2.11M
10-K · filed 2018-03-06
2015-09-30$392.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
-$1.48M
derived: sum of 2 quarters · filed 2016-11-03
$748.00K
10-Q · filed 2016-11-03
$1.80M
derived: sum of 4 quarters · filed 2017-03-16
2015-06-30-$1.88M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
$356.00K
10-Q · filed 2016-08-04
$1.41M
derived: sum of 3 quarters · filed 2017-03-16
$1.64M
derived: sum of 4 quarters · filed 2017-03-16
2015-03-31$2.23M
10-Q · filed 2016-05-05
$3.29M
derived: sum of 2 quarters · filed 2017-03-16
$3.52M
derived: sum of 3 quarters · filed 2017-03-16
$4.16M
derived: sum of 4 quarters · filed 2017-03-16
2014-12-31$1.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16
$1.29M
derived: sum of 2 quarters · filed 2017-03-16
$1.93M
derived: sum of 3 quarters · filed 2017-03-16
$2.29M
10-K · filed 2017-03-16
2014-09-30$234.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
$874.00K
derived: sum of 2 quarters · filed 2015-11-09
$1.23M
10-Q · filed 2015-11-09
$704.00K
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30$640.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31
$998.00K
10-Q · filed 2015-07-31
$470.00K
derived: sum of 3 quarters · filed 2016-02-29
$998.00K
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31$358.00K
10-Q · filed 2015-05-05
-$170.00K
derived: sum of 2 quarters · filed 2016-02-29
$358.00K
derived: sum of 3 quarters · filed 2016-02-29
$1.09M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31-$528.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$0.00
derived: sum of 2 quarters · filed 2016-02-29
$735.00K
derived: sum of 3 quarters · filed 2016-02-29
$760.00K
10-K · filed 2016-02-29
$760.50K
10-K · filed 2014-03-06
2013-09-30$528.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06
$1.26M
derived: sum of 2 quarters · filed 2014-11-06
$1.29M
10-Q · filed 2014-11-06
$1.29M
10-Q · filed 2013-11-14
$1.09M
derived: sum of 4 quarters · filed 2015-03-02
2013-06-30$735.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07
$760.00K
10-Q · filed 2014-08-07
$759.83K
10-Q · filed 2013-08-13
$558.09K
derived: sum of 3 quarters · filed 2015-03-02
-$5.50M
derived: sum of 4 quarters · filed 2015-03-02
2013-03-31$25.00K
10-Q · filed 2014-05-06
-$176.91K
derived: sum of 2 quarters · filed 2015-03-02
-$6.24M
derived: sum of 3 quarters · filed 2015-03-02
2012-12-31-$201.91K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
-$6.26M
derived: sum of 2 quarters · filed 2015-03-02
-$2.45M
10-K · filed 2015-03-02
-$2.45M
10-K · filed 2014-03-06
2012-09-30-$6.06M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14
-$2.25M
10-Q · filed 2013-11-14
2012-06-30$3.81M
10-Q · filed 2013-08-13
2011-12-31$1.36M
10-K · filed 2014-03-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
Dianthus Therapeutics, Inc. /DE/ (DNTH)United States$5.082B-27.79
Erasca, Inc. (ERAS)United States$5.073B-19.96
Gossamer Bio, Inc. (GOSS)United States$5.355B-0.65
Cogent Biosciences, Inc. (COGT)United States$5.450B-17.61
Veradermics, Inc (MANE)United States$4.839B
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
Edgewise Therapeutics, Inc. (EWTX)United States$4.470B-22.23
Viking Therapeutics, Inc. (VKTX)United States$4.287B-8.51